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Abstract
Background: Many Caenorhabditis elegans mutations increase longevity and much evidence suggests that they do
so at least partly via changes in metabolism. However, up until now there has been no systematic investigation of
how the metabolic networks of long-lived mutants differ from those of normal worms. Metabolomic technologies,
that permit the analysis of many untargeted metabolites in parallel, now make this possible. Here we use one of
these,
1H nuclear magnetic resonance spectroscopy, to investigate what makes long-lived worms metabolically
distinctive.
Results: We examined three classes of long-lived worms: dauer larvae, adult Insulin/IGF-1 signalling (IIS)-defective
mutants, and a translation-defective mutant. Surprisingly, these ostensibly different long-lived worms share a
common metabolic signature, dominated by shifts in carbohydrate and amino acid metabolism. In addition the
dauer larvae, uniquely, had elevated levels of modified amino acids (hydroxyproline and phosphoserine). We
interrogated existing gene expression data in order to integrate functional (metabolite-level) changes with
transcriptional changes at a pathway level.
Conclusions: The observed metabolic responses could be explained to a large degree by upregulation of
gluconeogenesis and the glyoxylate shunt as well as changes in amino acid catabolism. These responses point to
new possible mechanisms of longevity assurance in worms. The metabolic changes observed in dauer larvae can
be explained by the existence of high levels of autophagy leading to recycling of cellular components.
See associated minireview: http://jbiol.com/content/9/1/7
Background
The nematode Caenorhabditis elegans normally has a
life-span of about three weeks. The dauer larva, how-
ever, lives for up to eight times longer [1]. In addition,
mutations in scores of genes have been identified that
increase longevity. These genes have been grouped into
several pathways including the Insulin/Insulin-Like sig-
nalling pathway (IIS) [2-6], the dietary restriction path-
way [7,8] and the translation control pathway [9], but
how they regulate ageing individually and together is
still obscure. What is certain, however, is that each of
them influences the metabolism of the worm in some
fashion. This has been shown by the discovery that par-
ticular longevity pathways control, or at least interact
with, key regulators of metabolism [10-13] as well as
many metabolic enzymes [14-22].
Despite these advances, our understanding of how
altered metabolism influences longevity in worms,
indeed, if it does so at all, remains very incomplete. In
part, this is because attention has focused almost exclu-
sively on the genes that control metabolism rather than
metabolites themselves. Yet gene activity can only give a
very dim outline of the activity of a metabolic network
since much regulation occurs at the post-transcriptional,
or even post-translational level, for example, by allos-
teric interactions among metabolites and the enzymes
that catalyse them [23,24]. One way to investigate the
activity of metabolic network si nam o r ed i r e c tf a s h i o n
is metabolite profiling (also sometimes called metabolo-
mics or metabonomics). Metabolomics has been pre-
viously combined with functional genomics to study a
variety of biological problems and species [25-28]
including, recently, C. elegans [29-31]. Here, we apply it
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worms that are, for one reason or another, long-lived.
Most of our long-lived worms are defective for compo-
nents of the IIS pathway and one is translation defective;
but we also study the dauer stage that forms when lar-
vae are grown under stressful conditions. We show that
all these long-lived worms have metabolic profiles that
are not only very different from normal worms but also
very similar to each other; in other words, that there is
a metabolic signature for long-life in worms. The exis-
tence of this signature is surprising since the IIS and
translation pathways are, at least, thought to influence
longevity by quite distinct mechanisms [9,12]. This sig-
nature is composed of metabolites that function in sev-
eral distinct parts of the network, including
carbohydrate, amino acid and choline metabolism. Since
our ultimate goal is an integrated model of worm meta-
bolism, we also interrogate existing global gene expres-
sion data from daf-2 mutant worms [20] to give a
general account of how the metabolic networks of long-
lived worms differ from those with normal life-spans.
Results and discussion
Long-lived mutants have distinctive metabolic profiles
Of the various pathways known to regulate longevity in
worms, the best known is the Insulin/Insulin-Like sig-
nalling (IIS) pathway [32,33]. Many mutations that dis-
rupt components of this pathway affect the ability of
larval worms to enter and leave the dauer stage, but
they also increase the longevity and stress resistance of
adults as well as reduce their fecundity [2-6,34].
We began by studying m41, a hypomorph mutation
that disrupts daf-2 which encodes a tyrosine kinase that
is expressed throughout the worm and is thought to act
as a receptor for many of the 37 insulin-like ligands pre-
sent in the C. elegans genome [35,36]. daf-2(m41) her-
maphrodites are 10 to 90% longer-lived than wild-type
worms [3,17,37,38] (our data not shown). Since m41 is a
dauer-constitutive temperature-sensitive mutation we
grew these worms at the permissive temperature, 15°C,
until L4, transferred them to 22.5°C, and assayed their
metabolites as old adults (240 hours). We did this by
freezing the worms instantly in liquid nitrogen, extract-
ing polar metabolites, and then acquiring
1H NMR spec-
tra. The spectra showed a range of resonances from
small molecule metabolites, typical of tissue extracts.
We then divided the spectra into bins each chosen to
represent as far as possible a single metabolite reso-
nance. Principal components analysis (PCA) and hier-
archical cluster analysis (HCA) of the reduced data
showed that daf-2(m41) and wild-type samples have dis-
tinct metabolic profiles with little overlap between the
two groups of samples in PC1 (Figure 1A). The loadings
along this axis showed that many NMR-detectable
metabolites contribute to the difference between the
genotypes (Figure 1B).
Many IIS mutations exist and they differ in the sever-
ity and kind of their phenotypic effects [3,34]. So, in a
separate experiment we simultaneously studied three
daf-2 mutations: m41, e1370 and m596 as well as daf-28
(sa191) which disrupts an insulin-like ligand thought to
bind DAF-2. DAF-28 is thought to activate DAF-2 and
so promote normal, reproductive growth and longevity,
but sa191 is a dominant negative gain-of-function allele
[35]. Like daf-2 hypomorphs, daf-28(sa191) is partly
dauer constitutive, has long-lived adults, and can be
repressed by mutations in daf-16 [35]. In this experi-
ment, we used fewer samples of worms per genotype
than in previous experiments, but sampled three ages,
L1 (15 hours), middle-age (144 hours) and old age (240
hours), and raised them first at 15°C and then at 25°C.
Considering just the old-age samples we found that all
of these mutants have distinctive metabolic profiles,
with e1370 and m41 having respectively the least and
most distinctive metabolic phenotypes relative to wild-
type (Figure 2A). The rank order of allele strength for
longevity at 22.5°C and 25°C is e1370 <m41 <m596 (our
data not shown; [3]), but daf-2 alleles have a variety of
phenotypic effects which do not all show the same rank
order of severity [3,34,39]. The three daf-2 mutations
affect different parts of the receptor: e1370 disrupts the
intracellular tyrosine kinase domain while m41 and
m596 disrupt, respectively, the Cysteine Rich and Leu-
cine Rich L2 extracellular domains [34,39]. Some L2
domain mutations in the human Insulin receptors have
very low ligand binding affinity [40]; a similar property
of daf-2(m596) may explain why its metabolome resem-
bles that of daf-28(sa191) which disrupts a putative
ligand.
When surveying the four daf-2(-) mutants, we also
looked at another kind of long-lived mutant, ife-2
(ok306), which disrupts a gene encoding an isoform of
the eukaryotic translation initiation factor, eIF4E [9].
Since this mutation does not require DAF-16 to confer
increased longevity, it is thought that IFE-2 works either
downstream or in parallel to DAF-2 to regulate longev-
ity. We found that the metabolic profile of ife-2(ok306)
is very similar to that of the ILS mutants: cluster analy-
sis and PCA do not clearly separate ife-2(ok306) worms
from ILS mutants (Figure 2A).
Since we sampled all of our mutants at three ages we
were also able to study, at least crudely, when the
mutant worms acquired their distinctive metabolic pro-
files. PCA and cluster analysis shows that all mutants
had distinctive metabolic profiles even as larvae, but in
all cases the metabolic profiles became increasingly dif-
ferent from wild-type with age (Figure 2B). Since repro-
duction has not yet begun in L1 larvae, which do not
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l i v e dm u t a n t sc a n n o tb ee n t i r e l yd u et oad e c r e a s ei n
metabolic resources allocated to reproduction.
Finally, in this same experiment, we also studied dauer
larvae. Dauers form when L2 worms are crowded or
deprived of food. They do not feed, have very distinctive
transcriptional profiles, physiologies and morphologies,
are very stress resistant and also do not age [1]. We
raised dauers at two temperatures, 20°C (n = 3) and 25°
C (n = 5), and compared them to old adults (240 hours)
raised at the same temperatures (n = 5 for both). Clus-
tering and PCA showed that dauers and adults have
unambiguously distinct metabolic profiles as do worms
raised at different temperatures, with temperature
nested within the two stages (Figure 2C). Comparing
dauers to L1s or young adults gave very similar results
(data not shown). We found that metabolite levels
showed strong stage × temperature interactions. This is
reflected in the reversal of the relative positions of
dauers and adults along the PC 2 axis depending on the
temperature and also in analysis of variance on indivi-
dual bins (data not shown).
The metabolic signature of long life in worms
What are the metabolic features of long-life? In C. ele-
gans, many mutants and environmental treatments con-
fer increased longevity, but the devices by which they do
so, or whether or not they are the same, remains
unclear. One reason for this is that few studies assay
more than one class of long-lived worm using the same
technology and experimental conditions. Since we have
studied three classes of long-lived worm, dauers, IIS
d e f e c t i v ea n dat r a n s l a t i o n - d efective mutant, using the
same metabolic profiling technique, we can directly
compare them and ask what, if anything, do they have
in common?
To do this we determined the relative concentrations
of 26 metabolites (Figure 3A; Additional file 1). Then, to
identify the metabolic signatures of long-life we ranked
them by consistency and direction of response in long-
lived worms relative to wild-type (Figure 3B). Although
Figure 1 The insulin-signalling mutant daf-2(m41) has a distinctive metabolic profile. In this experiment m41 a n dN 2w i l d - t y p ew o r m s
were initially raised at 15°C, transferred to 22.5°C at L4, and assayed at 240 hours post-bleaching. A. PCA (above) on the binned spectra shows
that daf-2(m41) are clearly separable from N2 along PC1 (Means and 95% CI are given by ellipses); cluster analysis (below) separates the samples
into two groups, one predominantly wild-type (8/9), the other predominantly m41 (10/13). The first three PCs respectively account for 50, 11 and
7% of the variance. B. Heatmap (middle) showing the standardized relative concentration of 34 bins out of 179 with a substantial (>0.1 and
<-0.1) loading on PC1, their loads (below) and position on the
+1H NMR spectrum (above). The spectrum is the median of five N2 samples;
intensities >5.0 ppm are scaled by a factor of 10.
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here we focus on the single experiment in which worms
were raised at 25°C and sampled at 10 days after
hatching.
We found that the metabolic responses of our long-lived
worms were strikingly similar. More than half of the
examined metabolites show qualitatively similar changes
in dauers, IIS mutants, and ife-2 mutant worms. This
result was surprising since IIS and ife-2 mutations
ostensibly influence very different aspects of the worm’s
physiology. We propose that these metabolites consti-
tute a minimal metabolic signature of long-life in
worms.
One of the signature metabolites was the disaccharide
trehalose. An important carbohydrate storage molecule
in nematodes, trehalose is thought to confer stress resis-
tance in many invertebrates [41-43]. Previous studies
have shown that the expression of genes involved in its
synthesis are elevated in dauers and IIS mutants so our
finding that trehalose pool sizes are elevated in dauers
and IIS mutants was expected; indeed, trehalose has
been proposed as a longevity assurance sugar [19,44].
ife-2(ok306) worms show high trehalose levels as well
implying that a deficiency in protein synthesis can affect
carbohydrate metabolism as well.
This similarity across different classes of long-lived
worms is also seen in amino acid levels. Of the 12
amino acids we studied, 11 are regulated in IIS mutants.
Of these, 10 are regulated in the same way in ife-2
(oK306) and 5 are in dauers. We also found the follow-
ing metabolites consistently regulated across dauer, IIS,
and ife-2(0) mutants: choline, phosphocholine, and gly-
cerophosphocholine (GPC), which are associated with
lipid metabolism; acetate, malate and succinate, which
are associated with carbohydrate metabolism; propano-
ate and NAD
+. Some of these longevity-signature meta-
bolites are expected from previous studies of long-lived
worms. This is particularly true of metabolites that have
a role in carbohydrate metabolism and we consider
them in greater detail below. Others, such as altered
pool sizes of amino acids, choline, phosphocholine, pro-
panoate and NAD
+, could point to new mechanisms of
longevity assurance in C. elegans.W ea l s on o t et h a t ,
although we have ignored metabolic responses peculiar
to particular worm strains, we cannot exclude the possi-
bility that they influence longevity as well.
Autophagy and the dauer metabolome
Although the dauer metabolome resembles that of long-
lived mutants in many ways, we also found that it has
some unique features. We detected pools of two post-
translationally modified amino acids, phosphoserine and
hydroxyproline, in dauers and only dauers. Since hydro-
xylation and phosphorylation generally take place on
peptides rather than free amino acids, these pools are
Figure 2 Longevity mutants and dauer larvae have distinctive
metabolic profiles. A. PCA of four IIS mutants and a long-lived
translation-defective mutant, ife-2(ok306); cluster analysis separates
the mutants into distinct groups. daf-2(e1370) is the most similar to
wild-type. ife-2(ok306), while distinctive relative to wild-type and all
other mutants, is not distinctive relative to the IIS mutants as a class.
In this experiment mutant and wild-type worms were initially raised
at 15°C, transferred to 25°C at L4, and assayed at 240 hours post
bleaching. The first three PCs respectively account for 40, 20 and
16% of the variance. B. PCA shows that daf-2(m41) has a distinctive
profile even at L1 (15 hours); and appears to become successively
more distinctive as a middle-aged adult (144 hours) and old (240
hours) adult. The first three PCs explain, respectively, 35, 26 and 11%
of the variance. C. PCA of dauers and wild-type worms (240 hours)
raised at two temperatures, 20°C and 25°C. The PCA and cluster
analysis shows that dauers and adults clearly have distinct
metabolomes as do worms raised at 20°C rather than 25°C. The first
three PCs explain, respectively, 48, 16 and 11% of the variance, with
PC1 distinguishing stages and PCs 2 and 3 distinguishing
temperature. Note that the relative position of the samples raised at
the two temperatures is reversed along PC2, a consequence of
strong temperature × stage interaction.
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obvious source of free hydroxyproline is collagen: the C.
elegans genome contains approximately 175 genes
encoding collagens which are used in the basement
membranes and cuticle, two prolyl 4-hydroxylases, and
at least five peptidases that are required for the proces-
sing or turn-over of cuticle collagens [45,46]. The source
of free phosphoserine is less obvious, however, given
that we studied high concentration metabolites, they
probably are not derived from the phosphorylated ser-
ines found in signalling pathways but rather represent
structural components. We suspect that the phosphoser-
ine pool seen in dauers is derived from serine phospho-
glyceride lipids freed by turnover of membrane
phospholipids. This is supported by the observation that
choline compounds (choline, phosphocholine, and GPC)
are also strongly increased in dauers, and altered choline
compound concentrations are frequently observed in
mammalian tumours where they mark the membrane
turnover characteristic of rapidly proliferating cells [47].
Since dauers do not feed they rely on energy stores such
as fats and glycogen to survive, and much evidence
shows that the beta-oxidation and glyoxylate pathways
that metabolize fatty acids are upregulated in dauers
[19,48-50]. One explanation, then, for the elevated levels
of these modified amino acids is that dauers are utilizing
spare extracellular matrix, and other proteins, as yet
another energy store. Consistent with this idea, dauer
morphogenesis requires extensive autophagy [51]. A
mutation that abolishes autophagy also decreases long-
evity specifically in daf-2(e1370) which implies that high
levels of autophagy promote long-life [51]; if so we did
not detect any obvious signatures of this.
Some, but not all, signature metabolite responses require
DAF-16
Much evidence shows that the longevity prolonging
effects of IIS mutants are mediated by the FOXO tran-
scription factor, DAF-16 [2,52,53]. Down-regulation of
Figure 3 The metabolic signature of long-life. A. Relative concentrations of 26 metabolites in worms sampled at 25°C and 240 hours post-
hatching. B. Summary of metabolic responses. Here we show, for all experiments, the observed response in long-lived worms relative to
appropriate controls and rank them by their consistency; p values for individual experiment are given in each cell: * P < 0.05; ** <0.01; ***
<0.001; **** <0.0001. For all data and statistics see Additional file 1.
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hence activation of DAF-16 which, in turn, activates or
represses many genes which contribute to longevity
[14,54,55]. Since the longevity prolonging effect of daf-2
mutants is repressed by null mutations of daf-16,o n e
way of disentangling the phenotypes of IIS mutants that
contribute causally to longevity from those that do not,
is to ask whether they, too, depend on DAF-16 activity.
The reasoning, previously applied to transcriptomic and
proteomic data, is that any molecular phenotype that
contributes to longevity should be abolished by inhibit-
ing DAF-16 activity just as longevity itself [15,21].
To find out whether IIS control over metabolism was
also DAF-16 dependent we compared the metabolomes
of 144 hour-old wild-type worms to worms carrying
either another daf-2 allele, e1370,o rt h en u l ldaf-16
(m26) mutation, or both. Unsupervised methods (PCA
and HCA) divide these samples into two major groups:
a cluster which contains 7/8 daf-2(-) samples and a clus-
ter that contains the rest (Figure 4A). Thus the meta-
bolic phenotype of daf-2 is at least partially DAF-16
dependent; however the double mutants form a sub-
cluster clearly distinct from wild-type implying that not
all of the daf-2 phenotype is so.
By measuring metabolite levels directly in single
mutant daf-2(e1370) and daf-16(m26) and double
mutant daf-2(e1370);daf-16(m26) worms we were able
to apply this test to 11 metabolites (Figure 4B). Of these
only four, phosphocholine, and the closely related amino
acids isoleucine, valine, and leucine, showed the classic
pattern of DAF-16 dependence: concentrations of each
were substantially elevated or repressed in daf-2(-),b u t
not daf-16(0) or double mutant samples. Several other
metabolites showed more complex patterns of epistasis.
For example, lysine, lactate and glycerol concentrations
were all significantly different in either daf-16(0) or daf-
2(-);daf-16(0) worms or both compared to wild-type
worms (P=0.05; two-tailed t-test) and so fail the classi-
cal test of DAF-16 dependence. Surprisingly, trehalose
showed no sign of DAF-16 dependence: daf-16(0) sam-
ples have wild-type levels of the sugar, but double
mutants are not different from daf-2(-).T h i si si nc o n -
trast to previous results shown by transcriptomic studies
[15,19], which may perhaps reflect the fact that changes
in gene expression levels alone do not necessarily equate
to functional differences [56,57].
Classical DAF-16 dependence make isoleucine, valine,
leucine and phosphocholine strong candidates for hav-
ing a causal role in long life, particularly as all four are
signature metabolites as defined above. Conversely, the
absence of DAF-16 dependence in trehalose suggests
that DAF-2 regulates it via another transcription factor
parallel to DAF-16 and that it may not contribute to
long life. The interpretation of non-classical daf-16
epistasis is less clear. The classical test supposes that
DAF-16 is fully repressed in normal worms, but acti-
vated in the absence of DAF-2 signalling by transloca-
tion of the transcription factor from cytoplasm to nuclei
[55,58]. This model is certainly too simple since daf-16
(0) mutants have a variety of subtle phenotypes such as
rapid growth, early reproduction and a slightly reduced
lifespan, and normal worms have at least some DAF-16
visible in their nuclei [59,60]. Some metabolites are,
then, also apparently sensitive to low levels of DAF-16
activity.
Metabolic targets of DAF-2 signalling
We have shown that the pool sizes of many metabolites
differ between long-lived and normal worms and that
s o m eo ft h e s ed i f f e r e n c e sa r es h a r e db yv a r i o u sl o n g -
lived mutants, in particular the several daf-2 alleles that
we studied. But what genes does daf-2 regulate that
result in these changes? In order to investigate this, we
mapped some of our signature metabolites onto a stan-
dard metazoan metabolic network so that we could
identify those parts of the network that are altered in
daf-2 worms. We then asked whether the genes encod-
ing metabolic enzymes that work in the same parts of
the network are regulated as well, and if so, whether the
two sources of data could be used to give an economical
account of how the metabolism of C. elegans is altered
in daf-2 worms. As an initial guide we used NEMA-
PATH [61] to identify, for each metabolite, the pathways
in which they might work and the C. elegans genes that
might act in them. We then interrogated a previously
published global expression dataset based on daf-2
(e1370) worms raised under conditions similar to ours
[20] and examined the expression patterns of these
genes for patterns of co-regulation.
W ef o u n dt h a ta tl e a s tf i v eo ft h em e t a b o l i t e sr e g u -
lated in daf-2(-) worms, malate, acetate, succinate, glu-
cose and trehalose, were linked by three major
pathways: the glyoxylate shunt, gluconeogenesis, and
starch metabolism. Consistent with previous studies
[15,19,21] we found that genes encoding enzymes in
these pathways are up-regulated in daf-2(-) worms. In
all, the C. elegans genome contains 38 genes encoding
components of 20 enzymes that work in these pathways.
Of these 38 genes, 14 are significantly up-regulated, 5
are significantly down-regulated, 18 are not regulated,
and 1 has no data (Figure 5, Additional file 2).
While the observed shifts in carbohydrate metabolism
might have been expected from the results of gene
expression studies, the changes in amino acid metabo-
lism shown by our data were not. Most amino acid
pools are upregulated in long-lived worms (8/12 in the
IIS mutants; 10/12 in ife-2). One possible explanation
for this is that protein synthesis is generally repressed in
IIS mutants as it is in ife-2 [9] and that the amino acid
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reduced protein synthesis since the expression of their
t-RNA synthetases are generally repressed (Additional
file 2). However, there is no correlation between amino
acid pool size and tRNA synthetase expression (data not
shown). It is more likely then that amino acid pool sizes
are dictated by catabolic pathways that direct them to
energy production or other uses. Consistent with this,
many genes that encode components of phenylalanine
and tyrosine catabolic pathways, among them tyrosinase
and phenylalanine hydroxylase, are regulated in daf-2
(Additional file 2) [21,62]. Intriguingly, melanin, a tyro-
sine metabolite, has recently been discovered in worm
cuticles where it is thought to have a protective function
[63].
The most striking response among the amino acids,
however, is the upregulation of the branched chain
amino-acids (BCAAs) isoleucine, leucine and valine. The
pool sizes of these amino acids are positively correlated
across long-lived mutants (Figure 3A). Furthermore,
unlike most other metabolites, their upregulation in daf-
2 is entirely DAF-16 dependent, making them strong
candidates for being causally involved in longevity (Fig-
ure 4B). Like other animals, C. elegans cannot synthesize
these amino acids [64], and so any difference in their
relative concentrations must be due to a change in
either protein turnover or their catabolism. In fact,
BCAA pool sizes are co-regulated in many circum-
stances such as growth in worms [31] or obesity in
humans [65,66]. This co-regulation is a consequence of
Figure 4 DAF-16 dependence of metabolites. A. PCA of metabolic profiles of wild-type, single mutant daf-2(e1370) and daf-16(m26) and
double-mutant daf-2(e1370);daf-16(m26) samples. PCA and cluster analysis shows that daf-2(e1370) have the most divergent metabolism of the
four genotypes, implying that some of the distinctive features of the daf-2 metabolome is daf-16 dependent. The first three PCs explain,
respectively, 31, 21 and 13% of the variance; most of the separation between daf-2 and other genotypes is along PC2. In this experiment mutant
and wildype worms were initially raised at 15°C, transferred to 22.5°C at L4, and assayed at 144 hours post bleaching. B. Relative concentrations
of 11 metabolites in worms sampled at 22.5°C and 144 hours post hatch. Four metabolites - isoleucine, valine, leucine and phosphocholine -
show classical DAF-16 dependence, the rest show more complex patterns of epistasis or none.
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by three major pathways: the glyoxylate shunt, gluconeogenesis, and starch metabolism. Expression data [20] shows that these three pathways
(blue lines) are upregulated in daf-2(e1370) worms. Glycolysis and citric acid cycle genes (brown lines) are, by contrast, generally downregulated
or unregulated. In this model, carbon from acetate or fatty acid metabolism enters the glyoxylate pathway mediated by increased expression
isocitrate lyase (4.1.3.1) and malate synthase (4.1.3.2) which are encoded by a single gene, gei-7. The product of this pathway, malate, is then
converted to oxaloacetate by cytosolic malate dehydrogenase (1.1.1.37) which then results, via gluconeogenesis, to the production of
carbohydrates. The irreversible steps of gluconeogenesis are catalysed by phosphoenolpyruvate carboxykinase (4.1.1.32, PEPCK), pyruvate
carboxylase (6.4.1.1), and fructose 1,6-biphosphatase (3.1.3.11). Most of the genes encoding components of these enzymes are upregulated in
daf-2(-) worms. In most animals, glucose is synthesized from glucose-6-phosphate by glucose-6-phosphatase (3.1.3.9) but C. elegans does not
contain a homologue of this gene. We suppose, then, that glucose is produced by the metabolism of trehalose by trehalase (3.2.1.28). Several
trehalase genes are downregulated in daf-2 worms implying a reduced flux to glucose. However, glucose demand is also probably reduced
since two genes encoding hexokinase (2.7.1.1), responsible for a irreversible reaction in glycolysis, are repressed in daf-2 worms as are many of
the genes encoding the pyruvate dehydrogenase complex that links glycolysis to the citric acid cycle via acetyl-CoA. In contrast to the
glyoxylate pathway genes, TCA genes are not generally regulated in daf-2(-) worms. Genes and metabolites are taken to be regulated if P=0.05
(Additional file 2).
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ways: transamination by BCAT and oxidative carboxyla-
tion by the mitochondrial BCKD enzyme complex [65].
In daf-2(e1370) worms, BCAT expression is wild-type,
but all four genes encoding components of the BCKD
complex are strongly downregulated (Additional file 2).
We hypothesize that downregulation of the BCKD com-
plex is responsible for the increased BCAA pool sizes of
daf-2 worms. This hypothesis also suggests a way to
manipulate BCAA pool sizes to test their contribution
to long life. Strong inactivation of BCKD-complex genes
in worms causes severe embryonic and larval pheno-
types ([67]; wormbase.org) and, in humans, maple syrup
urine disease, a metabolic disorder resulting in encepha-
lopathy and death [68]; however, it remains possible
that more subtle elevation of BCAA levels by diet or
partial downregulation of the BCKD complex will confer
long life.
Conclusions
By studying the metabolic profiles of a range of long-
lived worms we have identified a metabolic signature of
long life common to dauers, IIS mutants and a transla-
tion defective mutant. Some of the metabolites that
comprise this signature, such as those involved in carbo-
hydrate metabolism, are expected from studies of global
gene expression; others, such as those involving amino
acid metabolism, are new. The existence of a common
metabolic signature for long life suggests that longevity
pathways that have been previously considered indepen-
dent may, in fact, regulate the same regions of the meta-
bolic network. By interrogating an existing global gene
expression profile dataset on daf-2 worms, we have
identified some of those regions. We find that the
changes in carbohydrate metabolism can be explained
by upregulation of the glyoxylate shunt and gluconeo-
genesis. We also find that the general elevation of
amino acid pool sizes in long-lived worms is likely due
to regulation of catabolic pathways that divert amino
acids away from protein synthesis and to energy meta-
bolism or other survival functions. Dauers show many
of the features of long-lived mutants, but they also show
elevated levels of phosphoserine, hydroxyproline, and
choline compounds; we suggest that these are probably
the consequence of extensive autophagy.
Although we have shown how the study of metabolite
concentrations and gene expression can be used
together to give a consistent account of the metabolism
of long-lived worms, we recognize that we have consid-
ered only a few of the many metabolic differences that
may give these worms their remarkable life-spans. Ulti-
mately, we would like to provide a general metabolic
model for long-life - one that quantitatively explains
longevity in terms of the expression of genes that
encode metabolic enzymes, the activity of those
enzymes, and the metabolic concentrations and fluxes
that result from them. That goal however, requires a
well-founded native metabolic network for C. elegans as
well as a general account of its kinetics and how they
are regulated, none of which currently exist. Neverthe-
less, the recent development of system-wide metabolic
models, particularly of microbes, suggests that such a
global model of C. elegans metabolism may be possible
in the near future [69-72]. Our study begins to provide
the empirical basis upon which it will depend.
Methods
Strains
We used the following strains: wild-type N2 Bristol,
DR26 daf-16(m26),C B 1 3 7 0daf-2(e1370),D R 1 5 6 4daf-2
(m41), DR1565 daf-2(m596), DR1309 daf-16;daf-2(m26;
e1370), JT191 daf-28(sa191),K X 1 5ife-2(ok306) and
RB579 ife-2(ok306), the outcrossed version of KX15.
They were provided by the Caenorhabditis elegans Cen-
ter (CGC) at the University of Minnesota.
Worm culture
Worms were grown using standard techniques. daf-2(-)
alleles are temperature-sensitive dauer constitutive. Syn-
chronized populations were grown at the permissive
temperature, 20°C, until L4 and then transferred to 22.5°
C or 25°C. Controls and non-ts strains were treated in
the same way. Dauers were induced by growing worms
as above but at high density. Worms were sampled for
NMR at either 15 h (L1), 144 h (adult, six days), or 240
h (adult, 10 days) post hatch. To ensure that only old
worms were sampled at 10 days, their offspring were
removed by repeated filtering using 50 μm Nitex mem-
branes (Sefar Ltd., Bury, UK).
Nuclear magnetic resonance (NMR) spectroscopy
For NMR analysis worms were washed off plates and
collected in 0.5 ml of M9 buffer [73], quick-frozen in
liquid nitrogen and stored at -80°C. We then ground
the tissue at liquid nitrogen temperatures in a mortar
and pestle, and added 2 ml ice-cold methanol directly to
the ground tissue to give a final concentration of 80%
methanol. We transferred the extract to microcentrifuge
tubes, and rinsed the mortars with an additional 2 ml of
80% methanol. We then centrifuged the extracts (10
minutes, 16,000 g) and dried the supernatants in a
rotary vacuum concentrator. We rehydrated each sam-
ple in 650 μl of NMR buffer (100%
2H2O, 0.97 mM
sodium trimethylsilyl-2,2,3,3-
2H4-propionate (TSP), 0.1
M phosphate buffer pH 7.0), centrifuged again to
remove any particulate matter, and transferred 600 μlt o
5 mm NMR tubes.
NMR spectra were acquired essentially as described by
Beckonert et al. [74] using a Bruker Avance DRX600
spectrometer (Bruker BioSpin, Rheinstetten, Germany)
Fuchs et al. BMC Biology 2010, 8:14
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1H resonance frequency, equipped with a 5 mm cryo-
genically-cooled inverse geometry probe. A 1D NOESY
pulse sequence was used for water suppression, with an
acquisition time of 1.36 s, and an additional relaxation
delay of 3.5 s, with presaturation during the relaxation
recovery and 0.1 s mixing time giving a 5 s recycle time;
we collected 160 transients per sample, following four
dummy scans to allow the system to approach a steady
state. The data were acquired into 32 K points over a 12
kHz spectral width.
NMR data processing and analysis
We carried out initial data processing in iNMR v.2. The
summed transients were multiplied by an exponential
apodization function equivalent to 0.5 Hz line broaden-
ing and zero-filled by 50%, followed by Fourier transfor-
mation. The spectra were referenced to the TSP
resonance at 0 ppm, and phase correction and first-
order baseline correction carried out using the soft-
ware’s proprietary algorithms. We visually identified
peaks in the spectra and divided them manually into
bins (integrals); compared to equal-interval binning of
the entire spectrum, this has the effect of reducing the
total number of variables, aligning each bin more closely
with an individual resonance, and excluding spectral
regions that contain only noise across all samples.
Around 40 detectable metabolites could be readily iden-
tified in routine 1D spectra of the worm extracts (Addi-
tional file 3). There were also a number of resonances
from as-yet unassigned metabolites (for example, sing-
lets at δ 1.993 and δ 1.986 ppm represent probable N-
acetyl groups). In addition, we re-processed all spectra
in Chenomx NMR Suite 4.6 (Chenomx, Edmonton, AB,
Canada) and quantified metabolite concentrations for
selected metabolites by computer-assisted manual fitting
of metabolites. This software fits idealized spectra made
up of combinations of Lorentzian peaks, based on
authentic standards [75]. We assigned metabolite reso-
nances by comparing their multiplicity and chemical
shift to compounds found in the Chenomx database.
This was supplemented by 2D NMR experiments
(COSY and HSQC) acquired for typical samples, and
additional comparisons to our own in-house standards
data and other online databases. All of the metabolites
fitted were present in the Chenomx proprietary data-
base, except for trehalose, which we added to the
database.
We then normalized the data by dividing each profile
by a single normalization factor, the median fold change
across all compounds relative to a reference profile (a
median of all profiles), as described by Dieterle et al.
[76], and log-transformed them by log10(ni +x ) .T h e
transformation reduced the dominating effect of the
high intensities of a few metabolites, so that intensity of
otherwise weak and insignificant peaks is increased. The
constant x was chosen such that the dependence
between standard deviation and intensity was removed
for a series of technical replicates, that is, increasing
homoscedasticity (the principle is discussed by Purohit
et al. [77], although a different transform was used by
these authors). Multivariate analyses (principal compo-
nents analysis, PCA, and hierarchical cluster analysis,
HCA) were performed in either Aabel (Gigawiz, Tulsa,
OK, USA) or JMP (SAS UK, Marlow, UK) as appropri-
ate. Using the fitted data (that is, from Chenomx), we
then tested the level of each metabolite in each experi-
ment against its appropriate control (Additional file 1).
In order to identify those metabolites that are generally
regulated across multiple longevity treatments, we used
aF i s h e r ’s combined probability test (Additional file 1,
Part 4). As an additional test of the overall consistency
in the pattern of regulation, we applied a sample rando-
mization test and found as a whole the data set is highly
structured (P < 1e-10).
Gene expression analysis
We downloaded Shaw et al.’s [20] gene expression data
from PUMAdb http://puma.princeton.edu/, and interro-
gated it for the expression of genes putatively encoding
all metabolic enzymes. In these experiments, daf-2
(e1370) worms were grown at 25°C and so the results
are also relevant to our data. Gene identities and meta-
bolic pathways were based on NemaPath [61], a version
of KEGG [78-80] native for nematode sequences http://
www.nematode.net/cgi-bin/keggview.cgi.
Additional file 1: Table S1. Metabolite concentrations in long-lived and
normal worms based on manual computer-aided fitting to 1H NMR
spectra (see Materials and Methods for further details).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1741-7007-8-14-
S1.PDF]
Additional file 2: Table S2. Expression of genes encoding enzymes in
selected metabolic pathways. Relative expression in daf-2(e1370) adults
compared to wild-type worms; data from reference [20].
Click here for file
[http://www.biomedcentral.com/content/supplementary/1741-7007-8-14-
S2.PDF]
Additional file 3: Table S3. List of assigned metabolites detected in
worm samples by 1D NMR, and associated resonance chemical shifts and
multiplicity. Only the most characteristic resonances are listed in the
table.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1741-7007-8-14-
S3.PDF]
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